Capstone Financial Advisors’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.47M Buy
5,710
+737
+15% +$224K 0.12% 46
2026
Q1
$1.06M Buy
4,973
+2,822
+131% +$631K 0.06% 60
2025
Q4
$368K Sell
2,151
-232
-10% -$36.1K 0.02% 120
2025
Q3
$319K Buy
2,383
+200
+9% +$21.2K 0.02% 136
2025
Q2
$212K Sell
2,183
-1,294
-37% -$103K 0.01% 154
2025
Q1
$253K Hold
3,477
0.02% 124
2024
Q4
$251K Sell
3,477
-3
-0.1% -$228 0.02% 127
2024
Q3
$284K Buy
3,480
+10
+0.3% +$869 0.02% 122
2024
Q2
$369K Buy
+3,470
New +$333K 0.02% 98

Other funds holding LRCX

Capstone Financial Advisors's LRCX Position: Q2 2026 in Review

Capstone Financial Advisors increased its Lam Research (LRCX) stake by 15% in Q2 2026, buying an estimated $224K and bringing the position to 5,710 shares worth $2.47M. The position accounts for 0.12% of the portfolio, ranked #46.

Capstone Financial Advisors first reported a position in LRCX in Q2 2024 and has held it in 9 quarters since. 3,131 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Capstone Financial Advisors held 5,710 shares of Lam Research worth $2.47M as of Q2 2026.
  • Capstone Financial Advisors bought 737 Lam Research shares in Q2 2026, an estimated $224K.
  • Lam Research made up 0.12% of Capstone Financial Advisors's portfolio in Q2 2026, its #46 holding.
  • Capstone Financial Advisors first reported a position in Lam Research in Q2 2024 and has held it in 9 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Capstone Financial Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.